Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > RAF265(CHIR-265)

RAF265(CHIR-265)

RAF265(CHIR-265) structure

RAF265(CHIR-265) 

structure
  • CAS No:

    927880-90-8

  • Formula:

    C24H15F6N6O

  • Chemical Name:

    RAF265(CHIR-265)

  • Synonyms:

    RAF265(CHIR-265);RAF265;CHIR-265 or RAF265;1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine;1-methyl-5-(2-(5-(trifluoromethyl)-1H-imidazol-2-yl)pyridin-4-yloxy)-N-(4-(trifluoromethyl)phenyl)-1H-benzo[d]imidazol-2-amine;1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amineRAF265 (CHIR-265);RAF 2651-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine;1H-Benzimidazol-2-amine, 1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

RAF265 is a potent RAF/VEGFR2 inhibitor.


1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-2-benzimidazolamine is an aromatic ether.

RAF265(CHIR-265) Basic Attributes

517.4059192

518.128967

-0

8O434L3768

Characteristics

80.6

5.4

1.5±0.1 g/cm3

667.6±65.0°C at 760 mmHg

357.5±34.3 °C

1.622

Drug Information

Investigated for use/treatment in melanoma.

CHIR-265 binds and inhibits Raf kinases, which may result in a reduction of tumor cell growth and proliferation, and tumor cell death. In addition, this agent inhibits vascular endothelial growth factor receptor type 2 (VEGFR-2), thereby disrupting tumor angiogenesis. Raf kinases are critical enzymes in the Ras/Raf/MEK/ERK signaling pathway and are frequently upregulated in neoplasms.

CHIR-265

RAF265(CHIR-265) Use and Manufacturing

RAF 265 is a multikinase inhibitor that has displayed BRAF inhibiting activity in clinical trials. It could be used in the treatment of a subpopulation of human melanoma tumors. Has cytotoxic effect of on MDA-MB-231 cells. RAF265 when used with BEZ-235 inhibited ERK, PI3K signaling that reduced growth, proliferation and development of drug resistance in human thyroid cancer cells.

Computed Properties

Molecular Weight:518.4
XLogP3:5.4
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:5
Exact Mass:518.12897813
Monoisotopic Mass:518.12897813
Topological Polar Surface Area:80.6
Heavy Atom Count:37
Complexity:763
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of RAF265(CHIR-265)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.